HIV-1 entry inhibitor entrances

被引:13
作者
Kuhmann, SE [1 ]
Moore, JP [1 ]
机构
[1] Cornell Univ, Joan & Sanford I Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10021 USA
关键词
D O I
10.1016/j.tips.2004.01.005
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
BMS-378806 is a newly described small-molecule inhibitor of human immunodeficiency virus type 1 (HIV-1) replication. It acts by binding to the gp120 surface glycoprotein of the virus within, or very close to, the pocket normally occupied by the CD4 antigen, the primary cell-surface receptor protein of HIV-1. Consequently, BMS-378806 inhibits gp120-CD4 binding and the subsequent events of virus-cell attachment and fusion. Thus, BMS-378806 or a derivative could be highly suitable to treat HIV-1 infection, and perhaps also to prevent infection when used in combination with other inhibitors of HIV-1 entry.
引用
收藏
页码:117 / 120
页数:4
相关论文
共 23 条
[1]   The molecular target of bicyclams, potent inhibitors of human immunodeficiency virus replication [J].
DeVreese, K ;
KoflerMongold, V ;
Leutgeb, C ;
Weber, V ;
Vermeire, K ;
Schacht, S ;
Anne, J ;
DeClercq, E ;
Datema, R ;
Werner, G .
JOURNAL OF VIROLOGY, 1996, 70 (02) :689-696
[2]   Biochemical and genetic characterizations of a novel human immunodeficiency virus type 1 inhibitor that blocks gp120-CD4 interactions [J].
Guo, Q ;
Ho, HT ;
Dicker, I ;
Fan, L ;
Zhou, NN ;
Friborg, J ;
Wang, T ;
McAuliffe, BV ;
Wang, HGH ;
Rose, RE ;
Fang, H ;
Scarnati, HT ;
Langley, DR ;
Meanwell, NA ;
Abraham, R ;
Colonno, RJ ;
Lin, PF .
JOURNAL OF VIROLOGY, 2003, 77 (19) :10528-10536
[3]  
Hammer Scott M., 2002, Top HIV Med, V10, P10
[4]   Biological and genetic characterization of a human immunodeficiency virus strain resistant to CXCR4 antagonist t134 [J].
Kanbara, K ;
Sato, S ;
Tanuma, J ;
Tamamura, H ;
Gotoh, K ;
Yoshimori, M ;
Kanamoto, T ;
Kitano, M ;
Fujii, N ;
Nakashima, H .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 2001, 17 (07) :615-622
[5]   Novel therapies based on mechanisms of HIV-1 cell entry [J].
Kilby, JM ;
Eron, JJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (22) :2228-2238
[6]  
KUHMANN SE, 2004, IN PRESS J VIROL
[7]   Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody [J].
Kwong, PD ;
Wyatt, R ;
Robinson, J ;
Sweet, RW ;
Sodroski, J ;
Hendrickson, WA .
NATURE, 1998, 393 (6686) :648-659
[8]   Enfuvirtide, an HIV-1 fusion inhibitor, for drug-resistant HIV infection in North and South America [J].
Lalezari, JP ;
Henry, K ;
O'Hearn, M ;
Montaner, JSG ;
Piliero, PJ ;
Trottier, B ;
Walmsley, S ;
Cohen, C ;
Kuritzkes, DR ;
Eron, JJ ;
Chung, J ;
DeMasi, R ;
Donatacci, L ;
Drobnes, C ;
Delehanty, J ;
Salgo, M ;
Farthing, C ;
Graham, E ;
Packard, M ;
Ngo, L ;
Lederman, M ;
Buam, J ;
Pollard, R ;
Rauf, S ;
Silkowski, W ;
Thompson, M ;
Rucker, A ;
Harris, M ;
Larsen, G ;
Preseon, S ;
Cunningham, D ;
Guimaraes, D ;
Bertasso, A ;
Kinchelow, T ;
Myers, R ;
Phoenix, BCBP ;
Skolnik, PR ;
Adams, B ;
Leite, OHM ;
Oliveira, M ;
Lefebvre, E ;
Gomez, B ;
Foy, KB ;
Lampiris, H ;
Charles, S ;
Dobkin, J ;
Crawford, M ;
Slom, T ;
Murphy, R ;
Mikaitis, T .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (22) :2175-2185
[9]   Efficacy of enfuvirtide in patients infected with drug-resistant HIV-1 in Europe and Australia [J].
Lazzarin, A ;
Clotet, B ;
Cooper, D ;
Reynes, J ;
Arasteh, K ;
Nelson, M ;
Katlama, C ;
Stellbrink, H ;
Delfraissy, J ;
Lange, J ;
Huson, L ;
DeMasi, R ;
Wat, C ;
Delehanty, J ;
Drobnes, C ;
Salgo, M .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (22) :2186-2195
[10]   A small molecule HIV-1 inhibitor that targets the HIV-1 envelope and inhibits CD4 receptor binding [J].
Lin, PF ;
Blair, W ;
Wang, T ;
Spicer, T ;
Guo, Q ;
Zhou, NN ;
Gong, YF ;
Wang, HGH ;
Rose, R ;
Yamanaka, G ;
Robinson, B ;
Li, CB ;
Fridell, R ;
Deminie, C ;
Demers, G ;
Yang, Z ;
Zadjura, L ;
Meanwell, N ;
Colonno, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (19) :11013-11018